139 related articles for article (PubMed ID: 30068257)
1. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.
Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A
Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257
[TBL] [Abstract][Full Text] [Related]
2. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
Arredondo A; Reyes G
PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
[TBL] [Abstract][Full Text] [Related]
3. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
Arredondo A; Zúñiga A
Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
[TBL] [Abstract][Full Text] [Related]
4. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
Arredondo A; Aviles R
PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
[TBL] [Abstract][Full Text] [Related]
5. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
Arredondo A; Zúñiga A; Parada I
Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
[TBL] [Abstract][Full Text] [Related]
6. [The cost of diabetes in Latin America: evidence from Mexico].
Arredondo A; De Icaza E
Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
Arredondo A; Azar A; Recamán AL
Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
[TBL] [Abstract][Full Text] [Related]
8. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
[TBL] [Abstract][Full Text] [Related]
9. Costs and financial consequences of the changing epidemiological profile in Mexico.
Arredondo A
Health Policy; 1997 Oct; 42(1):39-48. PubMed ID: 10173492
[TBL] [Abstract][Full Text] [Related]
10. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
Arredondo A; Cuadra SM; Duarte MB
BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
[TBL] [Abstract][Full Text] [Related]
11. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
[TBL] [Abstract][Full Text] [Related]
12. The cost of diabetes in Latin America and the Caribbean.
Barceló A; Aedo C; Rajpathak S; Robles S
Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
[TBL] [Abstract][Full Text] [Related]
13. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
[TBL] [Abstract][Full Text] [Related]
14. Obesity prevalence in Mexico: impact on health and economic burden.
Rtveladze K; Marsh T; Barquera S; Sanchez Romero LM; Levy D; Melendez G; Webber L; Kilpi F; McPherson K; Brown M
Public Health Nutr; 2014 Jan; 17(1):233-9. PubMed ID: 23369462
[TBL] [Abstract][Full Text] [Related]
15. Recent trends for the management of diabetes for older adults in the context of universal coverage and COVID-19: evidence from Mexico.
Arredondo A
Int Health; 2021 Sep; 13(5):488-491. PubMed ID: 33210109
[TBL] [Abstract][Full Text] [Related]
16. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
Arredondo A; Duarte MB; Cuadra SM
Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
[TBL] [Abstract][Full Text] [Related]
18. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
[TBL] [Abstract][Full Text] [Related]
19. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
[TBL] [Abstract][Full Text] [Related]
20. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.
Arredondo A; Azar A; Recaman AL
Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
